News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
285,904 Results
Type
Article (15499)
Company Profile (302)
Press Release (270097)
Multimedia
Podcasts (78)
Webinars (11)
Section
Business (81095)
Career Advice (410)
Deals (13476)
Drug Delivery (39)
Drug Development (50905)
Employer Resources (40)
FDA (5903)
Job Trends (5595)
News (147222)
Policy (10284)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Standard (2)
Academia (963)
Accelerated approval (20)
Adcomms (14)
Allergies (82)
Alliances (22224)
ALS (124)
Alzheimer's disease (1039)
Antibody-drug conjugate (ADC) (242)
Approvals (6095)
Artificial intelligence (267)
Autoimmune disease (111)
Automation (10)
Bankruptcy (105)
Best Places to Work (4648)
BIOSECURE Act (6)
Biosimilars (100)
Biotechnology (232)
Bladder cancer (102)
Brain cancer (45)
Breast cancer (345)
Cancer (3144)
Cardiovascular disease (239)
Career advice (351)
Career pathing (9)
CAR-T (217)
CDC (6)
Cell therapy (572)
Cervical cancer (14)
Clinical research (43827)
Collaboration (1160)
Company closure (2)
Compensation (591)
Complete response letters (39)
COVID-19 (1138)
CRISPR (86)
C-suite (561)
Cystic fibrosis (112)
Data (4337)
Denatured (15)
Depression (92)
Diabetes (258)
Diagnostics (1417)
Digital health (12)
Diversity (5)
Diversity, equity & inclusion (13)
Drug discovery (187)
Drug pricing (49)
Drug shortages (3)
Duchenne muscular dystrophy (213)
Earnings (31906)
Editorial (27)
Employer branding (6)
Employer resources (39)
Events (52104)
Executive appointments (631)
FDA (7666)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (9)
Frontotemporal dementia (22)
Funding (989)
Gene editing (185)
Generative AI (21)
Gene therapy (499)
GLP-1 (515)
Government (1205)
Grass and pollen (3)
Guidances (166)
Healthcare (6759)
HIV (18)
Huntington's disease (43)
IgA nephropathy (74)
Immunology and inflammation (191)
Immuno-oncology (39)
Indications (66)
Infectious disease (1243)
Inflammatory bowel disease (156)
Inflation Reduction Act (10)
Influenza (40)
Intellectual property (166)
Interviews (85)
IPO (7395)
IRA (12)
Job creations (1206)
Job search strategy (289)
JPM (41)
Kidney cancer (9)
Labor market (23)
Layoffs (249)
Leadership (13)
Legal (1463)
Liver cancer (41)
Longevity (11)
Lung cancer (422)
Lymphoma (252)
Machine learning (26)
Management (9)
Manufacturing (387)
MASH (130)
Medical device (2743)
Medtech (2752)
Mergers & acquisitions (6712)
Metabolic disorders (731)
Multiple sclerosis (103)
NASH (13)
Neurodegenerative disease (230)
Neuropsychiatric disorders (70)
Neuroscience (1964)
Neurotech (1)
NextGen: Class of 2026 (2112)
Non-profit (974)
Now hiring (30)
Obesity (331)
Opinion (138)
Ovarian cancer (131)
Pain (102)
Pancreatic cancer (161)
Parkinson's disease (234)
Partnered (12)
Patents (302)
Patient recruitment (330)
Peanut (43)
People (27077)
Pharmaceutical (45)
Pharmacy benefit managers (6)
Phase 1 (15516)
Phase 2 (20354)
Phase 3 (12906)
Pipeline (3268)
Policy (91)
Postmarket research (858)
Preclinical (6549)
Press Release (30)
Prostate cancer (145)
Psychedelics (50)
Radiopharmaceuticals (238)
Rare diseases (652)
Real estate (1515)
Recruiting (16)
Regulatory (10012)
Reports (19)
Research institute (999)
Resumes & cover letters (62)
Rett syndrome (24)
RNA editing (21)
RSV (16)
Schizophrenia (123)
Series A (182)
Series B (136)
Service/supplier (1)
Sickle cell disease (77)
Special edition (18)
Spinal muscular atrophy (119)
Sponsored (16)
Startups (2027)
State (1)
Stomach cancer (5)
Supply chain (32)
Tariffs (18)
The Weekly (62)
Vaccines (348)
Venture capital (69)
Weight loss (176)
Women's health (25)
Worklife (5)
Date
Last 7 days (347)
Last 30 days (1166)
Last 365 days (17955)
2026 (1671)
2025 (18249)
2024 (20757)
2023 (22620)
2022 (27022)
2021 (28033)
2020 (23928)
2019 (16624)
2018 (12100)
2017 (13936)
2016 (12014)
2015 (14541)
2014 (10681)
2013 (7802)
2012 (7685)
2011 (7748)
2010 (7523)
Location
Africa (190)
Alabama (65)
Alaska (3)
Arizona (71)
Arkansas (5)
Asia (18556)
Australia (3169)
California (7130)
Canada (1842)
China (779)
Colorado (248)
Connecticut (255)
Delaware (235)
Europe (39730)
Florida (907)
Georgia (209)
Hawaii (2)
Idaho (18)
Illinois (403)
India (35)
Indiana (164)
Iowa (8)
Japan (225)
Kansas (80)
Kentucky (9)
Louisiana (7)
Maine (11)
Maryland (760)
Massachusetts (5603)
Michigan (110)
Minnesota (248)
Mississippi (3)
Missouri (33)
Montana (16)
Nebraska (5)
Nevada (32)
New Hampshire (21)
New Jersey (1652)
New Mexico (14)
New York (1774)
North Carolina (830)
North Dakota (6)
Northern California (3497)
Ohio (181)
Oklahoma (11)
Oregon (24)
Pennsylvania (1343)
Puerto Rico (9)
Rhode Island (25)
South America (258)
South Carolina (9)
Southern California (2830)
Tennessee (42)
Texas (907)
United States (23551)
Utah (96)
Virginia (137)
Washington D.C. (38)
Washington State (594)
West Virginia (1)
Wisconsin (45)
285,904 Results for "forge therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Ascidian Therapeutics and Forge Biologics Announce Manufacturing Partnership to Advance RNA Editing Therapy for Stargardt Disease
January 8, 2026
·
3 min read
China
BMS Forges $1B+ Antibody Alliance With Chinese Firm Harbour
BMS is Harbour’s second powerhouse partner this year after the Chinese biotech signed a potential $4.68 billion deal with AstraZeneca in March.
December 17, 2025
·
1 min read
·
Tristan Manalac
Press Releases
Avista Therapeutics and Forge Biologics Announce AAV Development and cGMP Manufacturing Partnership
August 14, 2025
·
3 min read
Press Releases
Bionova Scientific and Syenex Forge Strategic Alliance to Expand Access to High-Quality Plasmid DNA for Advanced Therapies
January 9, 2026
·
4 min read
Press Releases
SCTbio and Fortrea Forge Strategic Collaboration to Accelerate Cell and Gene Therapy Development and Delivery
December 4, 2025
·
3 min read
Press Releases
Fangzhou and Fosun Pharma Forge Strategic Alliance to Deliver AI-Powered Psoriasis Management
October 29, 2025
·
3 min read
Press Releases
Bora Pharmaceuticals and Corealis Pharma Forge Strategic Alliance to Deliver Seamless, End-to-End Oral Solid Dose Development
December 10, 2025
·
2 min read
Press Releases
Made Scientific and Syenex Forge Technology Partnership to Transform T Cell Therapy Manufacturing
October 1, 2025
·
3 min read
Press Releases
Escugen and Sovran Forge Strategic Partnership Announcement
June 13, 2025
·
1 min read
Press Releases
AbTherx and Mosaic Biosciences Forge Exclusive Partnership to Provide Milestone and Royalty-Free Access to AbTherx’s Premier Human Antibody Discovery Technology
September 17, 2025
·
4 min read
1 of 28,591
Next
